TREATMENT PATTERNS, HEALTHCARE RESOURCE UTILIZATION, AND OUTCOMES FOR EARLY STAGE TRIPLE-NEGATIVE BREAST CANCER IN JAPAN - supplementary material

<b>Table S1. </b>List of anti-HER2 and hormone therapies<b>Figure S2.</b> Patient disposition (hospital claims data)<b>Figure S3.</b> Patient disposition (health insurance claims data)<b>Figure S4</b>. Kaplan–Meier plots of overall survival in patients with early stage breast cancer (Groups 1 and 2)<b>Figure S5</b>. Kaplan–Meier plots of event-free survival in patients with early stage breast cancer (Groups 1 and 2)